174 related articles for article (PubMed ID: 30254489)
21. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
22. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
[TBL] [Abstract][Full Text] [Related]
23. A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy.
Bi N; Cao J; Song Y; Shen J; Liu W; Fan J; He J; Shi Y; Zhang X; Lu N; Zhan Q; Wang L
PLoS One; 2014; 9(3):e91388. PubMed ID: 24637927
[TBL] [Abstract][Full Text] [Related]
24. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Liao X; Wang X; Huang K; Yang C; Yu T; Han C; Zhu G; Su H; Huang R; Peng T
Cancer Manag Res; 2018; 10():2537-2551. PubMed ID: 30127641
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.
Yang JS; Li BJ; Lu HW; Chen Y; Lu C; Zhu RX; Liu SH; Yi QT; Li J; Song CH
Tumour Biol; 2015 Apr; 36(4):3035-42. PubMed ID: 25501703
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Significance of Serum miR-22, miR-125b, and miR-15b in Non-Small Cell Lung Cancer Patients.
Shi GL; Zhang XY; Chen Y; Ma S; Bai WQ; Yin YJ
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538046
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.
Chen B; Gao T; Yuan W; Zhao W; Wang TH; Wu J
J Cancer; 2019; 10(23):5793-5804. PubMed ID: 31737116
[No Abstract] [Full Text] [Related]
28. Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions.
Liu T; You X; Sui J; Shen B; Zhang Y; Zhang XM; Yang S; Yao YZ; Yang F; Yin LH; Pu YP; Liang GY
J Cell Biochem; 2019 May; 120(5):7185-7198. PubMed ID: 30390338
[TBL] [Abstract][Full Text] [Related]
29. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
31. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
32. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
33. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.
Wang T; Lv M; Shen S; Zhou S; Wang P; Chen Y; Liu B; Yu L; Hou Y
PLoS One; 2012; 7(8):e43268. PubMed ID: 22937028
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
[TBL] [Abstract][Full Text] [Related]
36. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
37. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
[TBL] [Abstract][Full Text] [Related]
38. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
[TBL] [Abstract][Full Text] [Related]
39. Survival prediction of gastric cancer by a seven-microRNA signature.
Li X; Zhang Y; Zhang Y; Ding J; Wu K; Fan D
Gut; 2010 May; 59(5):579-85. PubMed ID: 19951901
[TBL] [Abstract][Full Text] [Related]
40. Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Jiang HG; Dai CH; Xu YP; Jiang Q; Xia XB; Shu Y; Li J
Oncol Lett; 2021 Nov; 22(5):792. PubMed ID: 34630703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
